End-of-day quote
Shenzhen S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
41.19
CNY
|
+0.98%
|
|
+11.41%
|
-12.92%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,393
|
1,600
|
12,833
|
3,401
|
2,870
|
2,441
|
-
|
-
|
Enterprise Value (EV)
2 |
1,393
|
1,600
|
12,833
|
3,235
|
2,630
|
2,134
|
2,065
|
1,971
|
P/E ratio
|
95.6
x
|
-216
x
|
51.5
x
|
63.8
x
|
45
x
|
30.4
x
|
23.8
x
|
19.5
x
|
Yield
|
-
|
-
|
-
|
0.33%
|
0.68%
|
0.65%
|
0.8%
|
1.07%
|
Capitalization / Revenue
|
7.88
x
|
8.94
x
|
58.3
x
|
13.3
x
|
9.79
x
|
7.17
x
|
5.46
x
|
4.54
x
|
EV / Revenue
|
7.88
x
|
8.94
x
|
58.3
x
|
12.6
x
|
8.97
x
|
6.26
x
|
4.62
x
|
3.67
x
|
EV / EBITDA
|
72.8
x
|
-955
x
|
335
x
|
52.7
x
|
36.1
x
|
23.4
x
|
17.2
x
|
14
x
|
EV / FCF
|
-
|
-
|
-
|
78.5
x
|
60.9
x
|
58.7
x
|
24.6
x
|
27.2
x
|
FCF Yield
|
-
|
-
|
-
|
1.27%
|
1.64%
|
1.7%
|
4.07%
|
3.68%
|
Price to Book
|
6.91
x
|
7.76
x
|
5.45
x
|
8.56
x
|
6.47
x
|
4.87
x
|
4.09
x
|
3.43
x
|
Nbr of stocks (in thousands)
|
405,760
|
403,836
|
401,920
|
427,862
|
430,653
|
429,414
|
-
|
-
|
Reference price
3 |
23.90
|
25.86
|
31.93
|
54.83
|
47.30
|
41.19
|
41.19
|
41.19
|
Announcement Date
|
2/28/20
|
4/23/21
|
4/14/22
|
4/11/23
|
4/11/24
|
-
|
-
|
-
|
1CNY in Million2USD in Million3CNY Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
176.8
|
179
|
220.2
|
256.2
|
293.1
|
340.7
|
447
|
537.8
|
EBITDA
1 |
19.15
|
-1.676
|
38.33
|
61.36
|
72.93
|
91.18
|
120
|
140.4
|
EBIT
1 |
15.03
|
-6.8
|
32.88
|
55.58
|
65.63
|
82.78
|
107.2
|
130.4
|
Operating Margin
|
8.5%
|
-3.8%
|
14.93%
|
21.7%
|
22.39%
|
24.3%
|
23.99%
|
24.24%
|
Earnings before Tax (EBT)
1 |
15.19
|
-6.856
|
38.75
|
55.51
|
65.5
|
77.02
|
108.5
|
132.1
|
Net income
1 |
14.32
|
-7.121
|
37.69
|
53.75
|
62.82
|
73.85
|
101.9
|
124.2
|
Net margin
|
8.1%
|
-3.98%
|
17.12%
|
20.98%
|
21.43%
|
21.68%
|
22.79%
|
23.1%
|
EPS
2 |
0.2500
|
-0.1200
|
0.6200
|
0.8600
|
1.050
|
1.353
|
1.731
|
2.116
|
Free Cash Flow
1 |
-
|
-
|
-
|
41.2
|
43.22
|
36.33
|
84.01
|
72.53
|
FCF margin
|
-
|
-
|
-
|
16.08%
|
14.75%
|
10.67%
|
18.79%
|
13.49%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
67.14%
|
59.26%
|
39.85%
|
70.04%
|
51.67%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
76.65%
|
68.8%
|
49.2%
|
82.45%
|
58.39%
|
Dividend per Share
2 |
-
|
-
|
-
|
0.1800
|
0.3200
|
0.2678
|
0.3311
|
0.4389
|
Announcement Date
|
2/28/20
|
4/23/21
|
4/14/22
|
4/11/23
|
4/11/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022 S1
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2023 S2
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
-
|
74.32
|
68.26
|
78.35
|
58.07
|
90.18
|
-
|
66.16
|
85.72
|
89.29
|
101.8
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
16.95
|
21.56
|
19.52
|
8.011
|
17.29
|
25.38
|
15.33
|
16.03
|
16.79
|
26.12
|
-
|
-
|
Operating Margin
|
-
|
22.81%
|
31.59%
|
24.91%
|
13.8%
|
19.17%
|
-
|
23.16%
|
18.7%
|
18.8%
|
25.66%
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
19.47
|
7.935
|
17.26
|
25.28
|
15.4
|
17
|
17.75
|
27.08
|
-
|
-
|
Net income
1 |
25.58
|
-
|
-
|
18.49
|
6.506
|
18.5
|
25.06
|
13.83
|
14.87
|
15.53
|
29.53
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
23.6%
|
11.2%
|
20.51%
|
-
|
20.9%
|
17.35%
|
17.4%
|
29.01%
|
-
|
-
|
EPS
2 |
0.4086
|
0.2900
|
0.3220
|
0.3129
|
0.1080
|
0.3067
|
-
|
0.2318
|
0.2460
|
0.2570
|
0.4886
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
0.3200
|
-
|
-
|
-
|
-
|
0.1834
|
-
|
-
|
Announcement Date
|
8/23/22
|
4/11/23
|
4/26/23
|
8/22/23
|
10/25/23
|
4/11/24
|
4/11/24
|
4/26/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
166
|
240
|
307
|
376
|
470
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
-
|
41.2
|
43.2
|
36.3
|
84
|
72.5
|
ROE (net income / shareholders' equity)
|
7.47%
|
-3.36%
|
16.8%
|
14.6%
|
15.2%
|
16.4%
|
17.6%
|
18.2%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
11.2%
|
-
|
13.4%
|
14.2%
|
14.8%
|
Assets
1 |
-
|
-
|
-
|
479.1
|
-
|
551.1
|
718.8
|
839.3
|
Book Value Per Share
2 |
3.460
|
3.330
|
5.860
|
6.400
|
7.310
|
8.460
|
10.10
|
12.00
|
Cash Flow per Share
2 |
0.4700
|
0.6700
|
0.7500
|
1.110
|
1.140
|
1.370
|
1.620
|
1.940
|
Capex
1 |
22.4
|
23.9
|
23.2
|
27.6
|
24.4
|
17.9
|
23.8
|
17
|
Capex / Sales
|
12.66%
|
13.35%
|
10.53%
|
10.77%
|
8.33%
|
5.25%
|
5.33%
|
3.17%
|
Announcement Date
|
2/28/20
|
4/23/21
|
4/14/22
|
4/11/23
|
4/11/24
|
-
|
-
|
-
|
Last Close Price
41.19
CNY Average target price
50.14
CNY Spread / Average Target +21.74% Consensus |
1st Jan change
|
Capi.
|
---|
| -12.92% | 2.44B | | -5.77% | 14.68B | | -40.71% | 2.71B | | -8.78% | 1.51B | | -.--% | 1.12B | | +40.66% | 518M | | +91.79% | 502M | | +1.67% | 183M | | -.--% | 168M | | -29.34% | 161M |
Medical Imaging Systems
|